CN1301968C - 取代的脲的类维生素a激动剂ⅱ - Google Patents

取代的脲的类维生素a激动剂ⅱ Download PDF

Info

Publication number
CN1301968C
CN1301968C CNB028178327A CN02817832A CN1301968C CN 1301968 C CN1301968 C CN 1301968C CN B028178327 A CNB028178327 A CN B028178327A CN 02817832 A CN02817832 A CN 02817832A CN 1301968 C CN1301968 C CN 1301968C
Authority
CN
China
Prior art keywords
alkyl
compounds
group
compound
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028178327A
Other languages
English (en)
Chinese (zh)
Other versions
CN1555357A (zh
Inventor
米夏埃尔·克劳斯
让－马克·拉皮埃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1555357A publication Critical patent/CN1555357A/zh
Application granted granted Critical
Publication of CN1301968C publication Critical patent/CN1301968C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB028178327A 2001-09-18 2002-09-11 取代的脲的类维生素a激动剂ⅱ Expired - Fee Related CN1301968C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32296201P 2001-09-18 2001-09-18
US60/322,962 2001-09-18

Publications (2)

Publication Number Publication Date
CN1555357A CN1555357A (zh) 2004-12-15
CN1301968C true CN1301968C (zh) 2007-02-28

Family

ID=23257206

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028178327A Expired - Fee Related CN1301968C (zh) 2001-09-18 2002-09-11 取代的脲的类维生素a激动剂ⅱ

Country Status (16)

Country Link
US (1) US6838472B2 (enExample)
EP (1) EP1430023B1 (enExample)
JP (1) JP4410562B2 (enExample)
KR (1) KR100891224B1 (enExample)
CN (1) CN1301968C (enExample)
AR (1) AR036532A1 (enExample)
AT (1) ATE427929T1 (enExample)
AU (1) AU2002340886B2 (enExample)
BR (1) BR0212607A (enExample)
CA (1) CA2458266C (enExample)
DE (1) DE60231888D1 (enExample)
ES (1) ES2325063T3 (enExample)
MX (1) MXPA04002305A (enExample)
PL (1) PL209697B1 (enExample)
RU (1) RU2303027C2 (enExample)
WO (1) WO2003024920A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1889830A1 (en) 2006-07-10 2008-02-20 Pharmeste S.r.l. Biarylcarboxyarylamides as vanilloid-1 receptor modulators
EP1889837A1 (en) * 2006-07-10 2008-02-20 Pharmeste S.r.l. VR1 vanilloid receptor antagonists with a iononic substructure
EP4066826B1 (en) 2010-09-01 2024-03-06 Thomas Jefferson University Retinoic acid receptor gamma agonists for muscle repair and regeneration
CN105188753B (zh) 2012-11-08 2018-12-18 国立大学法人山口大学 角结膜病症的治疗剂
DK3000466T3 (en) 2013-05-22 2018-11-26 Univ Yamaguchi INHIBITOR FOR RETINOCHOROIDAL DISEASES
CA3025854A1 (en) 2016-06-08 2017-12-14 Clementia Pharmaceuticals Inc. Methods for treating heterotopic ossification
EP3541380B1 (en) 2016-11-16 2021-12-15 Clementia Pharmaceuticals Inc. Methods for treating multiple osteochondroma (mo)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87821A1 (fr) * 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
HUT62558A (en) * 1991-07-01 1993-05-28 Sandoz Ag Process for producing n-phenylthiourea derivaties and pharmaceutical compositions comprising same
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5648514A (en) * 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US6093742A (en) * 1997-06-27 2000-07-25 Vertex Pharmaceuticals, Inc. Inhibitors of p38
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of invasive diseases, using selected anti-PAR materials

Also Published As

Publication number Publication date
CA2458266C (en) 2011-03-15
EP1430023A1 (en) 2004-06-23
MXPA04002305A (es) 2004-06-29
KR20040035808A (ko) 2004-04-29
RU2004111789A (ru) 2005-10-20
AU2002340886B2 (en) 2008-01-31
KR100891224B1 (ko) 2009-04-01
US20030125383A1 (en) 2003-07-03
BR0212607A (pt) 2004-08-17
WO2003024920A1 (en) 2003-03-27
AR036532A1 (es) 2004-09-15
CN1555357A (zh) 2004-12-15
JP4410562B2 (ja) 2010-02-03
PL370459A1 (en) 2005-05-30
ATE427929T1 (de) 2009-04-15
ES2325063T3 (es) 2009-08-25
DE60231888D1 (de) 2009-05-20
JP2005503411A (ja) 2005-02-03
US6838472B2 (en) 2005-01-04
PL209697B1 (pl) 2011-10-31
RU2303027C2 (ru) 2007-07-20
CA2458266A1 (en) 2003-03-27
EP1430023B1 (en) 2009-04-08

Similar Documents

Publication Publication Date Title
CN1107061C (zh) 趋化细胞因子受体－3拮抗剂
CN104030987B (zh) 二氢乳清酸脱氢酶抑制剂
CN1156451A (zh) 用作速激肽nk3受体拮抗剂的喹啉衍生物
CN1468207A (zh) 用于治疗肺气肿的新的类维生素a类化合物
CN1283621C (zh) 烷基脲的类维生素a激动剂ⅰ
CN1301968C (zh) 取代的脲的类维生素a激动剂ⅱ
CN1950359A (zh) 作为IkB激酶抑制剂的基本纯净的2－{ [2－(2－甲基氨基－嘧啶－4－基)－1H－吲哚－5－羰基]－氨基}－3－(苯基吡啶－2－基－氨基)－丙酸
US6770650B2 (en) Cyclic amine derivatives-CCR-3 receptor antagonists
AU2002329276A1 (en) Alkyl urea retinoid agonists I
US20050090504A1 (en) Piperidinyl and piperazinyl compounds substituted with bicyclo-heterocyclylalkyl groups useful as CCR3 receptor antagonists
US20040014775A1 (en) 2,5-substituted pyrimidine derivatives-CCR-3 receptor antagonists
AU2002340886A1 (en) Substituted urea retinoid agonists II
CN1296356C (zh) Ccr－3受体拮抗剂vii
JP2005502700A (ja) Ｃｃｒ−３受容体アンタゴニストｖ
CN1578776A (zh) 杂环类维生素a化合物
JP2004519443A (ja) Ｃｃｒ−３受容体拮抗薬としての置換ピロリジン
CN1048040A (zh) 乙醇胺衍生物的制备
MXPA98006690A (es) Antagonistas del receptor ccr-3
CN1086816A (zh) 乙醇胺衍生物的制备方法
TW200534846A (en) Compounds useful for the treatment of diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070228

Termination date: 20120911